Literature DB >> 16782342

"Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights.

M Bishr Omary1, Nam-On Ku, Guo-Zhong Tao, Diana M Toivola, Jian Liao.   

Abstract

Intermediate filaments (IFs) are major components of the mammalian cytoskeleton. They are among the most abundant cellular phosphoproteins; their phosphorylation typically involves multiple sites at repeat or unique motifs, preferentially within the "head" or "tail" domains. Phosphorylation and dephosphorylation are essential for the regulation of IF dynamics by modulating the intrinsic properties of IFs: solubility, conformation and filament organization, and, in addition, for the regulation of other IF post-translational modifications. These phosphorylation-regulated properties dictate generalized and context-dependent IF functions that reflect their tissue-specific expression. Most important among IF phosphorylation-mediated functions are the regulation of IF cellular or subcellular compartmentalization, levels and turnover, binding with associated proteins, susceptibility to cell stresses (including apoptosis), tissue-specific functions and IF-associated disease pathogenesis (where IF hyperphosphorylation also serves as a tissue-injury marker).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782342     DOI: 10.1016/j.tibs.2006.05.008

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  114 in total

1.  Autophagy regulates keratin 8 homeostasis in mammary epithelial cells and in breast tumors.

Authors:  Sameera Kongara; Olga Kravchuk; Irina Teplova; Fred Lozy; Jennifer Schulte; Dirk Moore; Nicola Barnard; Carola A Neumann; Eileen White; Vassiliki Karantza
Journal:  Mol Cancer Res       Date:  2010-06-08       Impact factor: 5.852

2.  Stressing the role of O-GlcNAc: linking cell survival to keratin modification.

Authors:  Jeremy D Rotty; Gerald W Hart; Pierre A Coulombe
Journal:  Nat Cell Biol       Date:  2010-09       Impact factor: 28.824

3.  O-GlcNAcylation determines the solubility, filament organization, and stability of keratins 8 and 18.

Authors:  Budnar Srikanth; Milind M Vaidya; Rajiv D Kalraiya
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

4.  Cytoskeletal keratin glycosylation protects epithelial tissue from injury.

Authors:  Nam-On Ku; Diana M Toivola; Pavel Strnad; M Bishr Omary
Journal:  Nat Cell Biol       Date:  2010-08-22       Impact factor: 28.824

5.  p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins.

Authors:  Manoj B Menon; Jessica Schwermann; Anurag Kumar Singh; Mirita Franz-Wachtel; Oliver Pabst; Ursula Seidler; M Bishr Omary; Alexey Kotlyarov; Matthias Gaestel
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

Review 6.  Keratins in health and cancer: more than mere epithelial cell markers.

Authors:  V Karantza
Journal:  Oncogene       Date:  2010-10-04       Impact factor: 9.867

7.  Type I keratin 17 protein is phosphorylated on serine 44 by p90 ribosomal protein S6 kinase 1 (RSK1) in a growth- and stress-dependent fashion.

Authors:  Xiaoou Pan; Lesley A Kane; Jennifer E Van Eyk; Pierre A Coulombe
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

8.  Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation.

Authors:  Miora Feinstein; Barak Markus; Iris Noyman; Hannah Shalev; Hagit Flusser; Ilan Shelef; Keren Liani-Leibson; Zamir Shorer; Idan Cohen; Shareef Khateeb; Sara Sivan; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2010-11-18       Impact factor: 11.025

Review 9.  Diseases of epidermal keratins and their linker proteins.

Authors:  Jouni Uitto; Gabriele Richard; John A McGrath
Journal:  Exp Cell Res       Date:  2007-04-24       Impact factor: 3.905

Review 10.  Post-translational modifications of intermediate filament proteins: mechanisms and functions.

Authors:  Natasha T Snider; M Bishr Omary
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.